Next week, a conference on Economic Dimensions of Personalized and Precision Medicine (PPM) will be held on September 13-14 in Santa Monica (LA, USA) organized by Ernst Berndt (MIT), Dana Goldman (USC), and John Rowe (Columbia U.) in the frame of a research program supported by the National Bureau of Economic Research. At this conference, I will present an overview of our Empirical economic analysis of orphan drug innovation as an example of PPM economic dimensions.